Web Results

law.justia.com/cases/federal/district-courts/california/cacdce/2:2013cv08080/575794/46

Peter Velasco et al v. Chrysler Group LLC, No. 2:2013cv08080 - Document 46 ( C.D. Cal. 2014) case opinion from the Central District of California U.S. Federal ...

www.law360.com/cases/527bfcb568f52d424a00a488

Parties, docket activity and news coverage of federal case Peter Velasco et al v. Chrysler Group LLC, case number 2:13-cv-08080, from California Central Court.

www.law360.com/cases/5481f97ac1b27137d4000003

Mar 30, 2017 ... Parties, docket activity and news coverage of federal case COX et al v. CHRYSLER GROUP, LLC, case number 3:14-cv-07573, from New ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4556144

Aug 25, 2015 ... Recent work by our group has shown that the oropharyngeal “phageome” .... 1.6. 3 (Love, Huber & Anders, 2014; McMurdie & Holmes, 2013; Wickham, 2009). ..... Jennifer R. Schroeder is an employee of Schroeder Statistical Consulting LLC. ... 2014;168:1303–1310. doi: 10.1176/appi.ajp.2011.11030516.

www.ncbi.nlm.nih.gov/pmc/articles/PMC3184471

Sep 30, 2011 ... Professional groups in the massage therapy community came together and established a .... conference calls), online collaboration tools (Basecamp; 37signals, LLC, Chicago, IL, USA), and e-mail. ..... Hertenstein MR, Holmes M, McCullough M, et al. ... Johansen-Berg H, Christensen V, Woolrich M, et al.

www.ajpb.com/journals/ajpb/2011/ajpb_sepoct2011/ajpb_11sepoct_thompson276to283

Sep 30, 2011 ... ... for docetaxel and cyclophosphamide (TC) versus doxorubicin and cyclophosphamide ... breast cancer (eAppendix A, available at www.ajpblive.com ). ... et al suggested a low risk of death or recurrence for TC patients after year 7, .... relapse, probably related to treatment, and all occurred in the AC group.

circgenetics.ahajournals.org/content/circcvg/7/2/144.full.pdf

Michael V. Holmes, MD, PhD; Holly J. Exeter, PhD; Lasse Folkersen, PhD;. Christopher P. Nelson ... Holmes et al Investigation Into the Role of sPLA2-V in CHD 145 ..... Humphries), FS/13/6/29977 (A.J.P. Smith), and the Medical Research. Council UK .... FC, et al. Group v secretory phospholipase A2 promotes atheroscle-.

www.tandfonline.com/doi/pdf/10.1080/15374416.2016.1138405

(Kessler et al., 2003) and an estimated annual economic burden of $83.1 ..... between maternal group and response type (error vs. cor- rect), F(2, 74) = 3.52, ...

physreports.physiology.org/content/5/9/e13258

May 4, 2017 ... 2014) and Parkinson's disease (PD) (Arnulf et al. ... which is neurotoxic to cells and leads to neuronal apoptosis (Holmes et al. ... One week after arrival, rats were separated into either normoxia (n = 13) or CIH (n = 18) treatment groups. ... were quantified using Proinflammatory Panel 1 (rat) V‐PLEX kit from ...

psych.wisc.edu/postlab/readings/Ferrarelli_2010_AJP.pdf

Sep 15, 2010 ... ajp.psychiatryonline.org. 1 ... (Am J Psychiatry Ferrarelli et al.; AiA:1–10) .... Group differences in spindle amplitude, duration, number, and .... phrenia patients versus medicated comparison subjects, and healthy versus medicated ..... owner of Promoter Neurosciences, LLC; and he holds patents for.